SYNCRIP/HNRNPQ-Related Neurodevelopmental Disorder

SYNCRIP-related neurodevelopmental disorder (also called HNRNPQ-RNDD) is a rare genetic condition caused by changes in the SYNCRIP gene, which plays an important role in how the brain develops and communicates. As part of the HNRNP gene family, SYNCRIP helps control how RNA is processed inside cells—a key step in making proteins that support learning, movement, and brain growth. The condition can vary widely from person to person, with some children mildly affected while others experience more significant challenges.

GeneSYNCRIP
InheritanceAutosomal Dominant
Published Cases45
First Described2021
Estimated Prevalence1 in 215,000
Key Publications

An expansion of the phenotype in individuals with SYNCRIP-Related Neurodevelopmental Disorder

(2024)

View PDF

Further evidence for de novo variants in SYNCRIP as the cause of a neurodevelopmental disorder

(2021)

View PDF
Understanding the Gene

What is SYNCRIP?

The Gene

SYNCRIP (also known as HNRNPQ) is a gene that helps control how RNA is processed inside cells. It's part of the larger HNRNP family of genes that regulate the messages cells use to build proteins. SYNCRIP is particularly important in the brain, where it helps neurons develop, communicate, and form the connections needed for learning and movement.

Why It Matters for the Brain

When one copy of SYNCRIP doesn't work properly, cells may not process RNA correctly. This can affect how the brain develops and functions. The good news is that most children with SYNCRIP-RNDD have mild to moderate challenges, and many make significant progress with the right therapies and support.

Science

The Genetics

Most variants are de novo, meaning neither parent carries the variant—it occurs as a new, spontaneous change. This means the chance of it happening again in the same family is generally very low. Diagnosis requires genetic testing, usually through whole exome sequencing, genome sequencing, or multigene neurodevelopmental panels.

Variant types observed:

  • Loss-of-function variants
  • Missense variants
  • Frameshift variants
  • Splice site variants
Research Findings

What's Happening Inside the Cell?

Researchers studied cells from affected individuals and observed several key patterns.

1

RNA processing role

SYNCRIP helps control how RNA messages are processed inside cells. When the gene doesn't work properly, this processing can be disrupted, affecting the proteins cells need to function.

2

Brain development

SYNCRIP is particularly important in the developing brain, where it helps neurons form connections and communicate with each other. Reduced function can affect learning, movement, and behavior.

3

Part of the HNRNP family

SYNCRIP belongs to the HNRNP gene family, which includes other genes like HNRNPC, HNRNPH1, and HNRNPU. All of these genes help regulate RNA and are important for brain development.

Medical Information

Clinical Features

The following clinical features have been observed in individuals with SYNCRIP-RNDD. Not all individuals will have all features, and the severity can vary significantly.

Learning & Development

~90%

Most children have developmental delay/intellectual disability ranging from borderline to moderate. Fine and gross motor delays are common, such as later walking and coordination difficulties. Speech delays are common and may be complicated by speech apraxia. Children continue to learn and develop throughout childhood with appropriate support.

Speech & Communication

~85%

Speech delay is very common. Some children speak in short sentences, while others use only a few words or rely on alternative communication (AAC). Speech therapy, including AAC devices, can make a significant difference.

Behavior & Social Differences

~80%

Many children have autism spectrum disorder or autistic characteristics. Attention difficulties and ADHD are frequently seen. Some children exhibit sensory differences, anxiety, or behavioral rigidity. Sleep disturbances or challenges have also been reported.

Muscle Tone & Movement

~40%

Hypotonia (low muscle tone) is common, especially in infancy. Some children develop mild balance or gait differences. Joint hypermobility may also be present. Physical and occupational therapy help improve strength and coordination.

Seizures

~30%

Some children experience seizures, including absence seizures or febrile seizures. Others may have abnormal EEG findings without obvious clinical seizures. Often, children with SYNCRIP-RNDD are diagnosed with seizures or epilepsy in early to mid childhood. Neurological evaluation is recommended.

Brain Differences

MRI findings, when present, may include structural brain differences, Chiari malformation, ventricular enlargement, or abnormalities in white matter or corpus callosum. Not all children have MRI findings.

Physical Features

Physical features are subtle and vary between children. Because these features are mild and inconsistent, they do not define the condition.

Eyes & Vision

~40%

Eye and vision differences have been observed among individuals with SYNCRIP-RNDD.

Kidney & Urinary System

~30%

Kidney anomalies have been observed.

  • Chronic kidney disease
  • Neurogenic bladder

Growth

Children may have typical growth, short stature, or overgrowth/higher weight percentiles. Patterns vary widely even within the same family.

Other Possible Features

Not every child will experience these, but they have been reported in some cases.

  • Feeding challenges in infancy
  • Sleep disturbances
  • Gastrointestinal concerns
  • Hearing or vision issues
  • Rare breathing differences
  • Kidney or cardiac findings (rare)
For Families

Newly Diagnosed?

Receiving a SYNCRIP-RNDD diagnosis can feel overwhelming, but you are not alone. While this is a rare condition, families and researchers are actively working together to understand it better. Every child is unique—the features described here represent what has been observed so far, and your child may experience a different combination. Most of the time, this condition occurs spontaneously (de novo), meaning parents did not pass the variant down and could not have predicted it.

Research

Experts On SYNCRIP

Meet the researchers advancing our understanding of SYNCRIP-RNDD.

Dr. Madelyn Gillentine

Dr. Madelyn Gillentine

Rare Disease Geneticist & Clinical Genomics Scientist

HNRNP Family Foundation

Dr. Gillentine serves as Research Director at the HNRNP Family Foundation, where she leads efforts to understand SYNCRIP-related neurodevelopmental disorder and other HNRNP conditions. Her research focuses on expanding the clinical phenotype and advancing our understanding of these rare genetic conditions.

Join Our Research

We are running a Natural History Study for SYNCRIP-RNDD at the HNRNP Family Foundation. Your participation helps advance research and treatment development.

Learn More & Enroll

Want to learn more about other HNRNP-RNDDs?

Explore our comprehensive resources on all HNRNP-Related Neurodevelopmental Disorders.

View All Disorders